Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Getinge appoints Stacy Beske as President Acute Care Therapies

GETI BRegulatory press release09.11.2026 klo 17.00
Download the release

Getinge has appointed Stacy Beske as President Acute Care Therapies and member of the Executive Team, reporting to Mattias Perjos, President & CEO. She will assume the position on December 1, 2026.

Beske joins Getinge from Philips where she most recently served as Senior Vice President, Business Unit Leader for Image Guided Therapy Devices. She holds a Ph.D. in Cardiovascular Physiology, has an extensive research background, and brings 20+ years of leadership experience across medtech, including image-guided therapy, diabetes, electrophysiology, diagnostics, and cardiovascular care.

"Stacy has a strong track record of leading complex businesses and transformations, building high-performing teams and turning strategy into results," says Mattias Perjos, President & CEO at Getinge. "This experience will be valuable as we deliver on our commitment to continue strengthening Acute Care Therapies by building on the progress made in recent years."

"I am very excited to join Getinge and to be leading Acute Care Therapies," says Beske. "The business has a strong portfolio and a crucial role in helping healthcare professionals improve outcomes for patients. I look forward to working with my new colleagues across the globe to build on that foundation, accelerate innovation and continue advancing the business."

Stacy Beske will be based at Getinge's office in Wayne, New Jersey. She succeeds Elin Frostehav, who will leave Getinge to take on an external opportunity after supporting a smooth transition.

Media contact:

Caroline Örmgård, Head of Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.